Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJohnson Matthey Regulatory News (JMAT)

Share Price Information for Johnson Matthey (JMAT)

Share Price is delayed by 15 minutes
Get Live Data
2,080.00    -62.00 (-2.89%)
Bid:
2,066.00
Ask:
2,070.00
Spread: 4.00 (0.194%)
Market Cap: £3.48b
JMAT Live PriceLast checked at - London Stock Exchange

Intraday Johnson Matthey Share Chart

Organisation Changes

20 Apr 2017 16:00

RNS Number : 9050C
Johnson Matthey PLC
20 April 2017
 

For release at 4.00 pm Thursday 20th April 2017

 

JM at 200 - Aligned for Growth

 

Johnson Matthey announces changes to its organisation

 

In 2017 Johnson Matthey celebrates its 200th year and in May we will launch a refreshed brand identity, "Inspiring science, enhancing life", to reflect our position as first and foremost a science led company which has a major positive impact on people's lives; making the world around us cleaner and healthier.

 

Johnson Matthey has made, and continues to make, significant progress in these areas but in order to perform in the current environment, we must increase our focus and build a more collaborative organisation. This will drive further synergies for customers and create value for shareholders. To achieve this, and to reinforce Johnson Matthey's brand identity, we will move to a group structure of four sectors aligned on the global priorities of cleaner air, the efficient use of natural resources and improved health:

· Clean Air

· Efficient Natural Resources

· Health

· New Markets

 

Clean Air is the new name for Emission Control Technologies Division. John Walker, Executive Director, will continue to lead this sector.

 

Efficient Natural Resources brings together Process Technologies Division and much of Precious Metal Products Division. There is an opportunity to deepen our presence in the chemicals, oil and gas, and industrial markets by enabling our customers to increase their efficient use of resources; making more out of less. Jane Toogood, currently Division Director of Precious Metal Products, will lead this sector.

 

Health will comprise much of our Fine Chemicals Division. Johnson Matthey is well positioned to build in this space through focusing on niche areas where we can differentiate using our expertise in complex chemistry. We will bring in a new leader from outside Johnson Matthey to head this sector. In the interim, Robert MacLeod, Chief Executive, will oversee this sector.

 

New Markets is the new name for our New Businesses Division. In addition to the current portfolio of businesses, it will incorporate the Medical Components business previously included in Precious Metal Products' Noble Metals business, and Fine Chemicals' Catalysis and Chiral Technologies business. Alan Nelson, currently Chief Technology Officer and Division Director of New Businesses, will lead this sector.

 

These changes are with immediate effect.

 

 

Enquiries:

Investor Relations

Simon McGough

Sarah Armstrong

 

Head of Investor Relations

Head of Investor Relations

 

020 7269 8235

020 7269 8426

Katharine Burrow

 

Media

Sally Jones

David Allchurch

Investor Relations Analyst

 

 

Director of Corporate Relations

Tulchan Communications

020 7269 8444

 

 

020 7269 8407

020 7353 4200

www.matthey.com

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEALLEALSXEFF
Date   Source Headline
5th Aug 20212:47 pmRNSDirector/PDMR Shareholding
5th Aug 202112:17 pmRNSDirector/PDMR Shareholding
5th Aug 202112:13 pmRNSDirector/PDMR Shareholding
5th Aug 202112:06 pmRNSDirector/PDMR Shareholding
5th Aug 202111:43 amRNSDirector/PDMR Shareholding
4th Aug 20214:22 pmRNSDirector/PDMR Shareholding
4th Aug 20214:08 pmRNSDirector/PDMR Shareholding
4th Aug 20213:51 pmRNSDirector/PDMR Shareholding
4th Aug 20213:34 pmRNSDirector/PDMR Shareholding
2nd Aug 20213:45 pmRNSHolding(s) in Company
30th Jul 20214:15 pmRNSHolding(s) in Company
29th Jul 202112:40 pmRNSResult of AGM
29th Jul 20217:00 amRNSDirectorate Change
29th Jul 20217:00 amRNSJohnson Matthey Q1 AGM trading update
22nd Jul 20214:24 pmRNSDirector/PDMR Shareholding
13th Jul 20215:39 pmRNSHolding(s) in Company
12th Jul 20214:05 pmRNSHolding(s) in Company
9th Jul 20215:01 pmRNSHolding(s) in Company
21st Jun 20213:15 pmRNSHolding(s) in Company
18th Jun 20213:54 pmRNSHolding(s) in Company
17th Jun 20213:56 pmRNSDirector/PDMR Shareholding
15th Jun 20219:00 amRNSAnnual Financial Report
10th Jun 20214:15 pmRNSHolding(s) in Company
27th May 20217:04 amRNSPreliminary results for year ended 31st March 2021
26th May 20217:00 amRNSJohnson Matthey and Plug Power green hydrogen MoU
20th May 202111:34 amRNSDirector/PDMR Shareholding
23rd Apr 20219:51 amRNSDirector/PDMR Shareholding
19th Apr 20217:00 amRNSStrategic developments in eLNO commercialisation
9th Apr 20214:10 pmRNSHolding(s) in Company
8th Apr 202111:10 amRNSHolding(s) in Company
8th Apr 20217:00 amRNSTrading update and strategic review of Health
24th Mar 202111:14 amRNSHolding(s) in Company
19th Mar 20213:00 pmRNSHolding(s) in Company
18th Mar 202111:53 amRNSDirector/PDMR Shareholding
9th Mar 20214:40 pmRNSHolding(s) in Company
8th Mar 202112:20 pmRNSHolding(s) in Company
24th Feb 20214:17 pmRNSDirector/PDMR Shareholding
18th Feb 20213:45 pmRNSDirector/PDMR Shareholding
16th Feb 20219:15 amRNSHolding(s) in Company
12th Feb 202110:15 amRNSHolding(s) in Company
8th Feb 20212:14 pmRNSDirector/PDMR Shareholding
8th Feb 20212:02 pmRNSDirector/PDMR Shareholding
22nd Jan 20214:15 pmRNSHolding(s) in Company
22nd Jan 202110:31 amRNSDirector/PDMR Shareholding
12th Jan 20217:00 amRNSAppointment of Chief Financial Officer
18th Dec 20203:29 pmRNSDirector/PDMR Shareholding
20th Nov 20202:55 pmRNSDirector/PDMR Shareholding
19th Nov 20207:00 amRNSJohnson Matthey half year results 30 Sept 2020
13th Nov 20204:45 pmRNSHolding(s) in Company
22nd Oct 20204:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.